/
MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

APUS — Apimeds Pharmaceuticals US, Inc.

NYSE American

Apimeds Pharmaceuticals US, Inc.

Back to Screener
$3.22
-0.88(-21.46%)
O
4.10
H
4.16
L
3.10
V
134.55K
⏱️ End-of-day dataAs of Oct 2, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

Apimeds Pharmaceuticals US, Inc. Statistics

Total Valuation

Market Cap$10.94M
Enterprise Value$10.08M

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Current Share Classn/a
Shares Outstanding1.51M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)n/a
Owned by Institutions (%)n/a
Floatn/a

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ration/a
Forward PSn/a
PB Ration/a
P/TBV Ration/a
P/FCF Ration/a
P/OCF Ration/a
PEG Ration/a

Enterprise Valuation

EV / Earnings-0.29
EV / Salesn/a
EV / EBITDA-0.83
EV / EBIT-0.29
EV / FCF-4.85

Financial Position

Current Ratio0.90
Quick Ration/a
Debt / Equity-0.20
Debt / EBITDA-0.01
Debt / FCF-0.06
Interest Coveragen/a

Financial Efficiency

Return on Equity (ROE)6026.29%
Return on Assets (ROA)-248.27%
Return on Invested Capital (ROIC)n/a
Return on Capital Employed (ROCE)n/a
Weighted Average Cost of Capital (WACC)n/a
Revenue Per Employeen/a
Profits Per Employee$-5,008,550
Employee Count7
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Taxn/a
Effective Tax Raten/a

Stock Price Statistics

Beta (5Y)n/a
52-Week Price Change-81.28%
50-Day Moving Average$4.01
200-Day Moving Average$7.09
Relative Strength Index (RSI)55.45
Average Volume (20 Days)6,486,795

Short Selling Information

Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Income Statement

Revenuen/a
Gross Profitn/a
Operating Income-$12.19M
Pretax Income-$35.06M
Net Income-$35.06M
EBITDA-$12.16M
EBIT-$34.20M
Loss Per Share$-2.26

Balance Sheet

Cash & Cash Equivalents$979.53K
Total Debt$118.81K
Net Cash$860.72K
Net Cash Per Share$0.57
Equity (Book Value)-$581.78K
Book Value Per Share$-0.39
Working Capital-$1.43M

Cash Flow

Operating Cash Flow-$25.94M
Capital Expenditures-$9.39K
Depreciation & Amortizationn/a
Net Borrowingn/a
Free Cash Flow-$2.08M
FCF Per Share$-1.38

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
Buyback Yieldn/a
Shareholder Yieldn/a
Earnings Yieldn/a
FCF Yield-18.98%

Analyst Forecast

Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Fair Value

Lynch Fair Valuen/a
Lynch Upsiden/a
Graham Numbern/a
Graham Upsiden/a

Stock Splits

Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

Altman Z-Scoren/a
Piotroski F-Scoren/a